University of Pennsylvania Medical Center
Locations
Transplant Summary
Overview
Transplants performed from related and unrelated donors using ablative and non-myeloablative conditioning, with marrow, blood stem cells and cord blood and Haplo transplants. Standard and investigational therapies available. Research focuses on improving safety, minimizing GVHD and enhancing graft-versus-tumor effect. We have treated over 687 patients with commercial car-T therapy since induction. We have recently onboarded Omisirge at our center.This center has been performing allogeneic transplants since 1996 and has been an NMDP transplant center since April 1999.
Attending physicians
Adult - Daria Babushok, Adam Cohen, Noelle Frey, Alfred Garfall, Saar Gill, Elizabeth Hexner, Rebecca Hirsh, Nasheed Mohammad Hossain, Daniel Landsburg, Alison Loren, Selina Luger, Mary Ellen Martin, Shannon McCurdy, Pashna Neville Munshi, Sunita Nasta, Alexander Perl, David Porter, Keith Pratz, Stephen Schuster, Edward Stadtmauer, Jakub Svoboda, Donald Tsai, Dan VoglTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult onlyOther programs and services
Mental health counseling, Nutrition support, Financial grant help, Hope, Lodge accommodation help, Transportation, Advocacy, Financial help with medication costs, Support group, Home care help, Advance directive help.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 356 patients.The actual 1-year survival of these patients is 74.4%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 71.6% and 80.1%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
669
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow19PBSC72Cord blood0Total91Unrelated donorMarrow16PBSC134Cord blood9Total159Total allogeneicMarrow35PBSC206Cord blood9Total250AutologousMarrowBoth marrow & PBSC 419PBSC—Cord blood—Total419Total combinedMarrowBoth marrow & PBSC 660PBSC—Cord blood9Total669All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-442545-644165+25Total91Unrelated 0-18019-443445-647265+53Total159Autologous 0-18019-445145-6420265+166Total419Total 0-18019-4411045-6431565+244Total669Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinatorLila QuinnPhone: (215) 964-1210NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
University of Pennsylvania
3400 Civic Center Blvd Philadelphia, PA 19104 Phone:215-615-5858 Staff
Program Director:Alison Loren, MD, Linda Perry, PA-CProgram Coordinator:Monika PatelMedical Specialties in Program
Allergy/immunology, cardiology, dentistry, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic transplant recipients
- Adults: 1 year after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital